Lack of association between acetylcholine receptor ε polymorphisms and early-onset myasthenia gravis

Muscle and Nerve

Volumn 29, Issue 3, 2004, Pages 436-439

  Bonifati, Domenico Marco ^a   Willcox, Nick ^a   Vincent, Angela ^a   Beeson, David ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine receptor; Congenital myasthenic syndrome; Epsilon subunit; Myasthenia gravis; Polymorphism

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; DNA; RECEPTOR SUBUNIT;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; UNITED KINGDOM;

ADULT; AGE OF ONSET; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GREAT BRITAIN; HUMANS; INDIA; INTRONS; MALE; MUTATION; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN SUBUNITS; RECEPTORS, CHOLINERGIC;

EID: 1442328900     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10548     Document Type: Article

References (16)

1. Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980;103:579-601.
2. Croxen R, Newland C, Betty M, Vincent A, Newsom-Davis J, Beeson D. Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome. Ann Neurol 1999;46:639-647.
3. Croxen R, Vincent A, Newsom-Davis J, Beeson D. Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations. Neurology 2002;58:1563-1565.
4. Demaine A, Willcox N, Janer M, Welsh K, Newsom-Davis J. Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity. J Neurol 1992;239:53-56.
5. Djabiri F, Caillat-Zucman S, Gajdos P, Jais JP, Gomez L, Khalil I, Charron D, Bach JF, Garchon HJ. Association of the AChR alpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmun 1997; 10:407-413.
6. Ealing J, Webster R, Brownlow S, Abdelgany A, Oosterhuis H, Muntoni F, Vaux DJ, Vincent A, Beeson D. Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR. Hum Mol Genet 2002;11:3087-3096.
7. Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, Pruitt JN II, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227.
8. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: progress over the past decade. Muscle Nerve 2003; 27:4-25.
9. Garchon HJ, Djabiri F, Viard JP, Gajdos P, Bach JF. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci USA 1994;91:4668-4672.
10. Heckmann JM, Morrison KE, Emeryk-Szajewska B, Strugalska H, Bergoffen J, Willcox N, Newsom-Davis J. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J Autoimmun 1996;9:175-180.
11. Hjehllstrom P, Peacock CS, Giscombe R, Pirskanen R, Lefvert AK, Blackwell JM, Sanjeevi CB. Polymorphism in tumor necrosis factor genes associated with myasthenia gravis. J Neuroimmunol 1998;88:137-143.
12. Huang D, Liu L, Noren K, Xia SQ, Trifunovic J, Pirskanen R, Lefvert AK. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 1998;88:192-198.
13. Huang D, Zheng C, Giscombe R, Matell G, Pirskanen R, Lefvert AK. Polymorphisms at -174 and in the 3′ flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis. J Neuroimmunol 1999;101:197-200.
14. Janer M, Cowland A, Picard J, Campbell D, Pontarotti P, Newsom-Davis J, Bunce M, Welsh K, Demaine A, Wilson AG, Willcox N. A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C. Hum Immunol 1999;60:909-917.
15. Merriman TR, Todd JA. Genetics of autoimmune disease. Curr Opin Immunol 1995;7:786-792.
16. Sieb JP, Kraner S, Rauch M, Steinlein OK. Immature endplates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations. Hum Genet 2000;107:160-164.